Isoproterenol-induced cardiomyopathy and exercise-induced cardiac hypertrophy
Summary:
Comparison of hearts of C57BL/6 males with isoproterenol-induced cardiomyopathy to those with exercise-induced cardiac hypertrophy. Results provide insight into the molecular differences between pathological and physiological cardiac hypertrophy models.
Galindo CL, Skinner MA, Errami M, Olson LD et al. Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol 2009 Dec 9;9:23. PMID: 20003209
